Podcast appearances and mentions of Mark Cuban

Today's word of the day is ‘shrinking' as in MLB as in ESPN as in NBC as in Netflix as in FOX as in TBS. What are we talking about? A new media rights deal was announced on Wednesday that will see Major League Baseball games on new networks. Where will each game be? Where can I watch what? Is this a good deal? (27:00) We have an update on the WNBA negotiations. More money. More revenue sharing. But still no deal. (35:15) Review: Midnight Run. (39:00) NPPOD. (43:00) Mark Cuban is back in the Mavericks inner circle. Wow. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Today's word of the day is ‘shrinking' as in MLB as in ESPN as in NBC as in Netflix as in FOX as in TBS. What are we talking about? A new media rights deal was announced on Wednesday that will see Major League Baseball games on new networks. Where will each game be? Where can I watch what? Is this a good deal? (27:00) We have an update on the WNBA negotiations. More money. More revenue sharing. But still no deal. (35:15) Review: Midnight Run. (39:00) NPPOD. (43:00) Mark Cuban is back in the Mavericks inner circle. Wow. Learn more about your ad choices. Visit podcastchoices.com/adchoices

“My most powerful content is when I lead with my voice as a mom because I have the same concerns about keeping my kids safe as my audience does. It's a powerful and effective way to find common ground with people,” says Dr. Jess Steier, a popular public health scientist and science communicator seeking to bridge divides and foster trust through empathetic, evidence-based communication. Dr. Steier has several platforms from which to do this work, including  Unbiased Science --  a communication hub that uses multiple social media platforms and other communications channels to share validated health and science information -- and as executive director of the Science Literacy Lab, a nonprofit organization dedicated to reaching a diverse audience seeking clarity and reliable information on scientific topics. “The science is less than half the battle,” she explains. “It's about how to communicate with empathy.”Join Raise the Line host Lindsey Smith for a valuable conversation that explores:What sources Dr. Steier relies on to validate informationHow she uses “escape room” exercises to train clinicians on empathetic communicationWhy tailored, story-driven messages reach audiences more effectively than facts.Mentioned in this episode:Unbiased Science If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

In this episode I sit down with Zain Zaidi, co‑founder and CEO of TransCrypts, to explore his personal story and the mission driving his startup. He shares how a misplaced grad‑school transcript sparked a blockchain solution for identity verification, how his company now serves millions of users and hundreds of enterprises, and why the deepfake era makes what they do more critical than ever. We dive into the tech, the regulatory hurdles, Web2 clients, Web3 opportunities, and what's ahead for verified credentials across employment, health and education.Key Learnings (with timestamps)00:00:00 – Mark Cuban's warning about digital misinformation and deepfakes; the trust crisis we face online.00:02:00 – Zain's personal trigger: grad‑school transcript error led to founding TransCrypts.00:04:00 – What TransCrypts solves: giving individuals ownership of verified credentials (job, school, income).00:06:00 – How the system works: integration with HR systems, issuance of on‑chain credentials.00:07:00 – Focus and expansion: employment verification is central, health and education credentials coming.00:12:00 – Technical and enterprise challenges: selling Web3 identity solutions to Web2 businesses.00:14:00 – The synergy of AI + crypto: identity verification as the defense against AI‑driven fraud.00:17:00 – Pitching and fundraising: cold‑emailing Mark Cuban, building traction, $15 M seed round.00:18:00 – Humanitarian use‑case: helping Ukrainian refugees access medical records via their platform.00:23:00 – If he were starting again today: focus on the solution not the tech; time your raise relative to market cycle.00:34:00 – Roadmap and ambitions: becoming a major employment/income data provider, potential token launch.Connecthttps://www.transcrypts.com/https://www.linkedin.com/company/transcrypts/https://x.com/transcrypts_https://www.linkedin.com/in/zainzaidi99/DisclaimerNothing mentioned in this podcast is investment advice and please do your own research.It would mean a lot if you can leave a review of this podcast on Apple Podcasts or Spotify and share this podcast with a friend.Be a guest on the podcast or contact us ‑ https://www.web3pod.xyz/

This week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor dive into your burning questions from around the world—exploring misunderstood metabolic problems, hard-won solutions for real people, and the science behind the headlines. From “selfish brain” physiology to the rollercoaster of insurance and medication access, Dr. Cooper brings clinical clarity and practical hope.Hear real-world listener stories, get advice on tuning your metabolic health, and learn why personalization—not “calories in, calories out”—leads to better outcomes. This is no silver bullet show: it's metabolic medicine, mythbusting, and science-backed encouragement for your journey.Key Questions AnsweredWhat is the “selfish brain” and how does it really impact blood sugar and diabetes risk?Why do GLP-1 medications affect stamina and hunger, and how should you fuel your body if you're using them?If insurance pulls coverage for medications like Ozempic or Zepbound, what are your practical, safe, and affordable options?How do metabolic markers, medication “cocktails,” and genetic testing shape Dr. Cooper's individualized care—and can you taper off meds and maintain results?What does “normal” blood sugar look like after meals, and how do you distinguish trends from outliers?Key TakeawaysMetabolism is complex—individualized care is essential. Diabetes, hypoglycemia, and insulin resistance all have personal causes and require testing like the Mixed Meal Tolerance Test to solve—not one-size-fits-all advice. GLP-1s require smart fueling. Many experience reduced stamina on these medications. Dr. Cooper recommends upping both complex and simple carbs pre-exercise and consulting with a registered dietitian if fatigue persists. Insurance coverage is a challenge—but not the end. Generic options (like liraglutide/Victoza via Mark Cuban Cost Plus Drugs), manufacturer programs, and “cocktail” regimens can support continued progress, even if you lose access to top-brand GLP-1s. Feedback loops & genetics drive lasting outcomes. While some patients can successfully—slowly—taper medications, most with metabolic dysfunction will need long-term support. “Clean eating” alone rarely reverses underlying feedback loop glitches. Monitoring is powerful. Using blood sugar monitors (especially for diabetics) can demystify meal spikes and help fine-tune nutrition and medication timing. Personal stories reflect broader truths. Listeners share struggles and solutions, reinforcing that metabolic health spans medication, motivation, and mindset.Dr. Cooper's Actionable TipsAlways dig deeper with testing—not just A1C but also post-meal spikes via the Mixed Meal Tolerance Test.If you're prescribed a GLP-1 and struggle with energy, increase carb intake safely and talk to a doctor about medication adjustment. For lost coverage, stick to FDA-approved sources: Lilly Direct for Zepbound, Novocare for Wegovy, and Mark Cuban for generics. Don't risk unregulated online compounds. Recognize the difference between generalized “healthy” habits and targeted strategies that actually move your biomarkers.Stay consistent and compassionate—focus on small improvements over extremes and absolutes.Notable Quote“The metabolism is regulated by a feedback loop…when you introduce outside hormone forms, you strengthen signals to favor fuel utilization over energy conservation.”— Dr. Emily CooperLinks & ResourcesPodcast Home: Fat Science Podcast WebsiteSubmit a Show Question: questions@fatsciencepodcast.com or dr.c@fatsciencepodcast.comDr. Emily Cooper on LinkedInMark Wright on LinkedInAndrea Taylor on InstagramGeneric medication access: Mark Cuban Cost Plus DrugsZepbound direct: Lilly DirectAdditional info: Novocare for WegovyFat Science is your source for breaking diet myths and advancing the science of true metabolic health. No diets, no agendas—just science that makes you feel better. The show is informational only and does not constitute medical advice.

Kirsten Maitland, co-founder and "CheeseMaster" of the critically acclaimed Rebel Cheese, recently joined The Ash Said It Show to pull back the curtain on the brand's meteoric rise. From military discipline to the largest vegan brie cavein the country, Maitland shared the surprising secrets behind her Shark Tank success and how she's converting die-hard dairy lovers one creamy, cultured wheel at a time. This episode is a must-listen for anyone interested in vegan food innovation, conscious business growth, and the power of a daring career pivot. Maitland was clear that the brand's success in creating the "world's best artisan vegan brie" comes from rejecting modern shortcuts. The company's commitment to traditional cheesemaking techniques—including the use of a temperature and humidity-controlled vegan brie cave—is non-negotiable. This meticulous aging process, she explained, is essential for cultivating the complex, "funky" flavor profiles and genuine textures that simply cannot be achieved with food science alone. The shocking truth? Most of Rebel Cheese's customers are not vegan. Maitland credited this conversion success to two key factors: flavor and familiarity. The cheeses are designed to function exactly like their dairy counterparts—they slice, melt, and hold up on a dairy-free charcuterie board. By focusing on replicating beloved classics like their Smoked Cheddar and Cave-Aged Brie, Rebel Cheese removes the intimidating element of the unknown for traditional cheese lovers. What non-obvious skill does a former Navy veteran entrepreneur bring to making plant-based cheese? Protocol Adherence and Adaptability. Maitland revealed that her experience as an Operations Specialist and later an Agile Coach in Big Tech taught her to build robust, repeatable processes (critical for food safety and quality control) while maintaining the agility to quickly iterate on recipes and scale production. This structure is the unseen foundation that supports the brand's artisanal quality at a mass scale. The Shark Tank investment from Mark Cuban and Lori Greiner caused an "explosion" in e-commerce orders. Maitland explained that scaling meant implementing a modular production system. Rather than sacrificing the small-batch, handcrafted process, they replicated it. They invested in equipment to handle the raw material processing (cashews) efficiently, but kept the culturing, aging, and finishing of the cheese strictly hands-on, ensuring the artisanal standard remains in every wheel shipped nationwide. Beyond the capital and media boost, Maitland's most valuable takeaway was the need for ruthless strategic focus. The Sharks' scrutiny forced the team to prioritize the most scalable, high-margin products—the ones that truly "rebelled" against expectations—allowing them to streamline their offerings and dominate the premium plant-based cheese market. In a transparent discussion, Maitland addressed the realities of running a high-growth business while staying true to its values. She emphasized that balancing the "values-led" mission with the demands of a "financially sustainable small business" requires transparent communication and strategic operational contractionswhen necessary. The core principle, she stated, is integrity—in their product, their financials, and their public messaging. Maitland sees the next major hurdle for high-end vegan food innovation not in replicating flavor, but in achieving price parity with dairy. The strategy for Rebel Cheese is to leverage increased volume and better supply chain relationships to drive down the cost of premium ingredients, ultimately making gourmet dairy-free foods accessible to the mass market and leading the charge into a truly plant-powered future. Web: https://rebelcheese.com Rebel Cheese is the critically acclaimed, Austin, Texas-based gourmet food company and brick-and-mortar bistro that is revolutionizing the plant-based cheese industry. Founded by the dynamic, globe-trotting duo, Kirsten Maitland and Fred Swar, Rebel Cheese has successfully challenged the notion that high-quality, artisanal cheese requires dairy, becoming a globally recognized brand in the vegan food and dairy-free charcuterie space. The brand was born out of co-founder Kirsten Maitland's personal journey to find flavorful, satisfying, and sophisticated vegan cheese alternatives after adopting a plant-based diet. She recognized a massive gap in the market: while basic dairy-free cheeses existed, none truly captured the complex textures, sharp flavors, and aging processes of traditional European cheeses. Rebel Cheese's mission is simple yet audacious: to create handcrafted, gourmet plant-based cheeses that are indistinguishable from their dairy counterparts in taste, texture, and melting properties. They achieve this by using old-world cheesemaking techniques—including culturing, aging, and ripening—but substituting cow or goat milk with a base of organic cashew milk and fava bean protein. Rebel Cheese gained massive national attention after appearing on the hit show Shark Tank. The company impressed the notoriously skeptical investors, with billionaire Mark Cuban quickly becoming an investor after declaring their products, particularly the Brie, tasted exactly like traditional cheese. For customers outside of Texas, Rebel Cheese ships its artisanal cheeses and curated gift boxes nationwide, bringing its award-winning plant-based cheese directly to consumers across the country. Ash Brown: Your Ultimate Guide to Inspiration, Empowerment & Action Looking for a motivational speaker, authentic podcaster, or influential media personality who can spark your journey toward personal growth? Meet Ash Brown — a dynamic American powerhouse known for her uplifting energy, relatable wisdom, and unwavering commitment to helping others unlock their full potential. Ash is a: Captivating event host Insightful lifestyle blogger Popular podcast creator Trusted voice in personal development Her mission? To empower individuals with real-world strategies, positive mindset tools, and actionable advice that lead to lasting transformation. Discover Ash Brown's World AshSaidit.com – Lifestyle Blog & Event Hub Explore exclusive event invites, honest product reviews, and daily inspiration through Ash's vibrant online platform. AshSaidit.com is your go-to destination for personal growth content, wellness tips, and authentic storytelling. The Ash Said It Show – Top-Ranked Podcast With over 2,100 episodes and 700,000+ global listens, Ash's podcast features inspiring interviews, life lessons, and empowerment stories from changemakers across industries. Each episode delivers practical tools and encouragement to help listeners thrive. Why Ash Brown Is a Leading Voice in Personal Development Ash Brown stands out for her: Authentic Optimism – Her contagious positivity helps audiences embrace challenges with confidence Relatable Advice – Ash shares unfiltered, honest insights that resonate across cultures and backgrounds Actionable Strategies – From mindset shifts to goal-setting, Ash equips listeners with tools to create real change Whether you're seeking career motivation, emotional resilience, or daily inspiration, Ash Brown is the trusted guide to help you rise. Website: AshSaidit.com Podcast: The Ash Said It Show (available on Spotify, Apple Podcasts, Google Podcasts) Connect with Ash Brown: Goli Gummy Discounts: https://go.goli.com/1loveash5 Luxury Handbag Discounts: https://www.theofficialathena.... Review Us: https://itunes.apple.com/us/po... Subscribe on YouTube: http://www.youtube.com/c/AshSa... Instagram: https://www.instagram.com/1lov... Facebook: https://www.facebook.com/ashsa... Blog: http://www.ashsaidit.com/blog #atlanta #ashsaidit #theashsaiditshow #ashblogsit #ashsaidit®Become a supporter of this podcast: https://www.spreaker.com/podcast/ash-said-it-show--1213325/support.

n this episode Derek Champagne, CEO of The Artist Evolution, interviews Tim Sanders. Tim Sanders spent most of his early career on the cutting edge of innovation and change. He was an early stage member of Mark Cuban's Broadcast.com, which had the largest opening day IPO in history. After Yahoo acquired the company, Tim was tapped to lead their ValueLab, and by 2001, he rose to Chief Solutions Officer. In 2005, he founded Deeper Media, which provides consulting services for leading brands. Today, he is one of the top-rated speakers on the lecture circuit.Tim is the author of four books, including the New York Times bestseller Love Is the Killer App: How To Win Business & Influence Friends. It's been translated into over a dozen languages and has been featured in Fast Company, USA Today, the New York Times, The Boston Globe, Christian Science Monitor and on CNN. He's a master storyteller who offers listeners actionable takeaways that produce results right away. That's why he's one of the top speakers on the lecture circuit.Learn more at www.timsanders.comBusiness Leadership Series Intro and Outro music provided by Just Off Turner: https://music.apple.com/za/album/the-long-walk-back/268386576

Hello, all you great people trying to figure out how to do right by patients. Welcome to it. I was and am always extremely curious if any of what we talk about over here on Relentless Health Value has, in any way, percolated over to your average employer CEO—the ones who do not listen to this show, I mean. For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. This is what I try to figure out during my conversation upcoming here with John Quinn from Wellnecity® today, and I score some advice to boot for employers in the face of any of these revelations that they may have. That's what's gonna go down today, and this whole endeavor is a decent plan, if I do say so myself, because John Quinn chats up a lot of employer CEOs. He's certainly got a bit of a catbird seat there. So, taking it from the top, I wanted to see how clued in these employer C-suites might be to a fundamental myth, which, if employer folks don't realize it is in fact a myth, it means that a whole lot of transformational power is going nowhere fast. And this myth is the mother of all myths: the "there is a market in healthcare" myth. We've been on a tear about this for three episodes now, at least as it relates to hospitals and health systems. I'm gonna refer everybody to LinkedIn because Luke Trocchio put up a, I don't know what you call it, a reel, highlighting something that Shane Cerone said in episode 490. And then I'm gonna tell you why whatever CEOs at self-insured employers are thinking here makes all the difference in the world. But what Shane said is this, "The myth is that we have a functioning marketplace, and we don't." Shane continues, "What I mean by [there is no actual healthcare market], as somebody who's been a CEO of multiple hospitals and health systems, hospitals don't compete on price for patients. It … doesn't work that way. And so, we don't really have a normal market incentive to reduce cost or, in this case, the price of services in order to remain competitive." Now look, and this isn't rocket science, but it needs to be said out loud. The reason there is no healthcare market largely is because self-insured employers have not insisted upon there being one. Is that fair? I don't know. And whether or not it's fair is irrelevant to this point. Self-insured employers pay for healthcare for, like, 160 million Americans. They are largely the demand curve. They are the demand side of any market that exists. Because you know something that doesn't our market make? You can't ask the supply side to create demand elasticity. You can't get a seller to get a buyer to buy or not buy at some price point. That would be like a comedy skit. Except in this case, you know, patients die or go bankrupt because they can't afford care. So, it's not really all that funny. But if in this country we are depending on health system prices being constrained by a market, and then you don't have a buyer who doesn't buy when the price is higher than the buyer wants to pay or a buyer who doesn't buy unsafe stuff or low-quality goods or services, you're gonna get sky-high prices. Welcome to it right now. Also, if there's no competition, again, no market. But competition a lot of times doesn't surface if there's no point in starting up a business because there's no demand for lower prices or higher-quality care. I mean, if no one cares if you have lower prices or higher quality, then how are you gonna attract patient volume or steal market share, right? Like, unless you're really good at marketing, I guess, or have accumulated market power. I'll say this again. If our whole, the whole healthcare sector pricing structure is built on the myth that there is a market and then there's no market and employers aren't filling for whatever reason, the vital demand side role that they have to play for there to be a market, then, right … hello, 37% renewals like we see coming up in New Jersey. Listen to the show with Kevin Lyons (EP487, Part 1). So, I say all this to say, do employer CEOs even know they have one job here? And I'm not talking about, again, whether or not this is fair, whether they're capable of pulling this off. I'm just distilling this whole thing down to this is the question that remains on the ground. So anyway, this is first and foremost what I go after John Quinn from Wellnecity to figure out today: Where's your average CEO in this learning curve? Now here's some demand curve optimism. The show from two weeks ago with Elizabeth Mitchell (EP491) from PBGH, the Purchaser Business Group on Health. In that show from a couple weeks ago, we talk about what PBGH members, who are very large employers, what they're up to. So, certainly go back and listen to that if you haven't. Okay, so with that, here's my conversation with John Quinn from Wellnecity, as I have mentioned; and you'll get two things out of this conversation. Number one, a level set on what employers' leadership teams are figuring out and why they are figuring this out. (Renewal shocks and employees complaining about affordability much?) But also how the mindset needs to shift in the C-suite for anything to really happen here. In other words, what's the assignment and what's some very top-line advice to get there? That's how I finish up the conversation with John Quinn today. Do just wanna note that Wellnecity so kindly offered to pick up some of the tab to produce this Relentless Health Value show, which, as I keep saying is … yeah, it is expensive to keep this train on the track. People often forget it's not just what goes into the recording, the hosting, the producing, the editing of a podcast, but there also is a whole Web site and an API feed and headshots and graphics and transcriptions and a proofreader. It's a whole thing, guys, even if the host is a volunteer with a day job. So, thanks much to Wellnecity for the contribution to the fund and for coming on the pod today. John Quinn is CEO of Wellnecity. Wellnecity does health plan management for employers that self-fund their health plan. The key role Wellnecity plays is how do they help those employers better manage the spend category called health benefits. This podcast, as I said, is partially sponsored by Wellnecity and also Aventria Health Group. Also mentioned in this episode are Wellnecity; Luke Trocchio; Shane Cerone; Kevin Lyons; Elizabeth Mitchell; Purchaser Business Group on Health (PBGH); Paul Holmes; Peter Hayes; Healthcare Purchaser Alliance; Mark Cuban; Lauren Vela; Cora Opsahl; Andreas Mang; Jon Camire; Eric Bricker, MD; and Christine Hale, MD, MBA. For a list of healthcare industry acronyms and terms that may be unfamiliar to you, click here. You can learn more at Wellnecity and follow John on LinkedIn.   John Quinn is the founder and CEO of Wellnecity, a health tech innovator on a mission to measurably improve the quality and affordability of employer-sponsored health plans in the United States. Under John's leadership, Wellnecity developed the groundbreaking Smart Hub platform, which integrates data from multiple vendors to simplify health plan management. Smart Hub enables organizations to measure ROI objectively, uncover savings, enhance member engagement, and reduce fiduciary risk. Building on this foundation, Wellnecity has launched its next-generation plan management platform, equipping HR leaders with real-time oversight, vendor accountability, and measurable ROI. The platform empowers leaders to act in the moment, redirecting spend, simplifying oversight, and delivering better healthcare for employees. John is also the author of Benefits Revolution: The Next Generation of Employer-Sponsored Healthcare and is widely regarded as a thought leader in the healthcare space. He believes healthier businesses are built on smarter healthcare for employees, and that data is the key to driving this transformation. Prior to founding Wellnecity, John spent 25 years at Andersen Consulting, Diamond Technology Partners, and McKinsey & Company. He advised Global 1000 companies and high-growth start-ups, helping them build new businesses, products, and channels. His expertise in digitized information and network effects has driven meaningful business model innovation. John is a sought-after speaker on topics such as the benefits revolution, the power of data, fixing what's broken, and health tech leadership. Helping organizations deliver innovation is his mission; fixing what's broken is his passion.   07:06 Why CEOs are looking more closely at healthcare spend. 08:06 EP397 with Paul Holmes. 08:21 How savings and health benefits are directly connected. 10:45 EP436 with Elizabeth Mitchell. 11:46 What missed earnings look like in relation to healthcare. 14:27 How costs have been shifting to employees for years, and why this doesn't work anymore. 17:36 EP475 with Peter Hayes. 18:23 What employers need to do instead of cost shift. 19:12 EP406 with Lauren Vela. 21:30 Why it's important to make health benefit changes at the speed of business, not at the speed of the benefits year. 26:17 Why is it important to put a finance function into your benefits? 27:10 EP488 with Mark Cuban and Cora Opsahl. 27:33 EP478 (Part 1) with Andreas Mang and Jon Camire. 27:35 Why daily data matters. 31:10 EP487 (Part 1) with Kevin Lyons. 31:21 Why it's important to hold vendors accountable. 31:47 Why it's important to move on from vendors who can't hold up to your scrutiny and needs. 33:46 EP472 with Eric Bricker, MD. 34:46 EP471 with Christine Hale, MD, MBA.   You can learn more at Wellnecity and follow John on LinkedIn.   John Quinn gives advice to #employer #CEOs on the #healthcaremarket on our #healthcarepodcast. #healthcare #podcast #financialhealth #patientoutcomes #primarycare #digitalhealth #healthcareleadership #healthcaretransformation #healthcareinnovation   Recent past interviews: Click a guest's name for their latest RHV episode! Dr Sam Flanders and Shane Cerone (EP492), Elizabeth Mitchell (EP491), Shane Cerone and Dr Sam Flanders (Part 1), Dan Greenleaf (Part 2), Dan Greenleaf (Part 1), Mark Cuban and Cora Opsahl, Kevin Lyons (Part 2), Kevin Lyons (Part 1), Dr Stan Schwartz (EP486), Dr Cristin Dickerson

“I realized that rather than talking one-to-one with patients in the exam room, you could talk one-to-many on social media,” says Dr. Kevin Pho, explaining the origins of KevinMD, the highly influential information sharing site he created for physicians, medical students and patients twenty years ago. Since then, KevinMD has become a valuable space for clinicians and patients to share stories and perspectives on topics from burnout and moral injury to technology and trust. In this conversation with Raise the Line host Michael Carrese, Dr. Pho reflects on the dual paths that have defined his career: as a practicing internal medicine physician and as one of healthcare's most trusted online voices. And despite the challenges of doing so, Dr. Pho encourages other medical providers to follow his lead. “Patients are going online, and if physicians are not there, they're going to get information that's perhaps politically-driven or simply inaccurate.”This thoughtful conversation also explores: How social media has reshaped health communicationThe risks and rewards for clinicians of having an online presence Why medical schools should teach negotiating skillsMentioned in this episode:KevinMDEstablishing, Managing and Protecting Your Online Reputation If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Is playing Purdy the right move for the 49ers? Mark Cuban is getting back involved with the Mavericks? Are the Seahawks legit Super Bowl contenders?

On today's episode, Kara welcomes Sarah Moret, Founder and CEO of Curie — the clean personal care brand on a mission to prove that “clean” can be powerful.Sarah's journey began with a personal frustration: she couldn't find a natural deodorant that actually worked. A marathon runner and wellness enthusiast, she set out to change that — investing $12,000 of her savings and spending more than a year perfecting a formula that delivered on both performance and purity. The result? Curie, a high-performance, aluminum-free deodorant that quickly grew from a small side hustle into an 8-figure business sold in over 4,500 stores nationwide, including Walmart and Anthropologie, and featured in locker rooms at Equinox and SoulCycle.Before founding Curie, Sarah worked in venture capital, where she invested in early-stage wellness startups — experience that gave her the insight and drive to build her own brand from the ground up. We talk about her journey from investor to entrepreneur, the lessons she's learned about formulating clean products that truly work, and how she's scaling Curie while staying true to her mission and values. From her Shark Tank deal with Barbara Corcoran and Mark Cuban to building a brand that's redefining the meaning of clean, this episode is full of lessons and inspiration for founders and consumers alike. Don't miss it! Are you interested in sponsoring and advertising on The Kara Goldin Show, which is now in the Top 1% of Entrepreneur podcasts in the world? Let me know by contacting me at karagoldin@gmail.com. You can also find me @‌KaraGoldin on all networks. To learn more about Sarah Moret and Curie:https://ww.curiebod.com/https://www.instagram.com/curiebod/https://www.instagram.com/sarahjmoret/https://www.linkedin.com/in/sarahmoret/ Sponsored By:Odoo - Discover how Odoo can take your business to the next level, by visiting Odoo.comSquare - Get up to $200 off Square hardware when you sign up at square.com/go/karagoldinLinkedIn Jobs - Head to LinkedIn.com/KaraGoldin to post your job for free. Check out our website to view this episode's show notes: https://karagoldin.com/podcast/766

Today's episode features two people who are shaking up the U.S. healthcare system in very different but deeply humane ways. Dr. Fumiko Chino knows firsthand how devastating medical debt can be. After losing her husband to cancer and being left with overwhelming bills, she went to medical school to become a radiation oncologist and made it her mission to make care more affordable.Mark Cuban, best known as one of the “sharks” on Shark Tank, is tackling the same problem from another angle. Through his Cost Plus Drug Company, he's disrupting the industry with a transparent, direct-to-consumer model that's already changing — and saving — lives.Together, Fumiko and Mark offer a hopeful glimpse of what's possible when empathy meets innovation.Join us on Instagram @beforewegopodcast for more stories, behind-the-scenes moments, and reflections on living and dying.Interested in learning more about upcoming TED events? Follow these links:TEDNext: ted.com/futureyou Hosted on Acast. See acast.com/privacy for more information.

“We've created this ecosystem where the vast majority of information on social media, particularly in nutrition science, is inaccurate or misleading,” says Dr. Jessica Knurick, a registered dietitian and Ph.D. in nutrition science specializing in chronic disease prevention. As you'll learn on this episode of Raise the Line with host Lindsey Smith, countering that trend has become Dr. Knurick's focus in the past several years, and her talent for translating complex scientific information into practical guidance has attracted a large following on social media. Beyond equipping her audience with the tools to think critically and make informed choices for themselves, she also wants them to make the connection between the generally poor health status of most Americans with public policies on food and health and advocate for more beneficial approaches. “We can create systems that put the most people in the position to succeed versus putting the most people in the position to fail.” Tune in to learn from this trusted voice on nutrition, food policy, and public health as she shares her perspectives on: Strategies for risk reduction and behavior changeWhat can rebuild trust in medical information How you can cut through the noise and spot misinformation onlineMentioned in this episode:Dr. Knurick's WebsiteTikTok ChannelInstagram FeedFacebook Page If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Soderbergh's second film for Mark Cuban's Magnolia Pictures was THE GIRLFRIEND EXPERIENCE, a largely improvised look at life on the cusp of the Great Recession starring adult film megastar Sasha Grey. We're joined by an anonymous writer and sex worker to talk about one of Soderbergh's less-appreciated great films, sex work as work, Grey's legacy, depictions of intimacy, and Power Wash Simulator for the Nintendo Switch. Really great episode, we hope you enjoy! Further Reading: Playing The Whore: The Work of Sex Work by Melissa Gira Grant "The Teenager & The Porn Star" by Dave Gardetta "Exploitation Under Capitalism" by Mary Mother of God "Whorearchy 101" by Jack Parker Soderbergh interview by Ben Walters Steven Soderbergh: Interviews, ed. Anthony Kaufman Further Viewing: RED DESERT (Antonioni, 1964) KLUTE (Pakula, 1971) CRIES AND WHISPERS (Bergman, 1972) FULL FRONTAL (Soderbergh, 2002) BUBBLE (Soderbergh, 2005) FASHIONISTAS SAFADO: THE CHALLENGE (Stagliano, 2006) MAGIC MIKE (Soderbergh, 2012) ANORA (Baker, 2024)   Follow Pod Casty For Me: https://www.podcastyforme.com/ https://twitter.com/podcastyforme https://www.instagram.com/podcastyforme/ https://www.youtube.com/@podcastyforme Support us on Patreon: https://www.patreon.com/PodCastyForMe Artwork by Jeremy Allison: https://www.instagram.com/jeremyallisonart  

He made nine figures by finding patterns in basketball, from the skycap counter of the Winnipeg airport to high-stakes athlete encounters in Vegas. Then Bob Voulgaris brought his dark-alley secrets to Mark Cuban's front office. Now, as scandal infects the integrity of the game, he sees a path forward — including, but not limited to, maybe turning Victor Wembanyama into The Bachelor. Hosted on Acast. See acast.com/privacy for more information.

In this episode, host Stacey Richter speaks with Dr. Sam Flanders and Shane Cerone about creating a high-quality hospital management model focused on surviving at 150% of Medicare costs. They discuss the inefficiencies in health systems and practical solutions to improve them without compromising quality.  The conversation covers the importance of empowering frontline staff, adopting continuous improvement models like Toyota's, and the critical role of employers in reshaping market dynamics through direct negotiation and price transparency. The episode emphasizes actionable steps for hospital executives, plan sponsors, and employers to drive significant improvements in healthcare efficiency and affordability. === LINKS ===

Could studying the DNA of extinct animals – or even bringing them back to life – help us save today's endangered species and inform modern medicine?  That may sound like the premise for a Hollywood movie, but it's work that our Raise the Line guest, Dr. Beth Shapiro, is actually engaged in as Chief Science Officer at Colossal Biosciences, which describes itself as the world's first and only de-extinction company.  “It's not just about learning about the past. It's learning about the past so we have more validated scientific information that we can use to predict what we can do to better influence the future,” she tells host Michael Carrese. An internationally-renowned evolutionary molecular biologist and paleogeneticist, Dr. Shapiro is a pioneer in ancient DNA research and has successfully sequenced genomes, like that of the dodo, to study evolution and the impact on humans. At Colossal Biosciences, she leads teams working to bring back traits of extinct species such as the mammoth, not for spectacle, but to restore ecological balance. “When species become extinct, you lose really fundamental interactions between species that existed in that ecosystem. By taking a species that's alive today and editing its DNA so that it resembles those extinct species, we can functionally replace those missing ecological interactions.” Tune into this utterly fascinating conversation to hear about what Jurassic Park got wrong, the positive ecological impact of reintroducing giant tortoises to Mauritius, and the ethics of using gene editing and other biotechnologies. Mentioned in this episode:Colossal Biosciences If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Just wrapped my second year chairing the EO Deal Exchange Conference, and the lessons were off the charts. Here's what happens when you put hundreds of entrepreneurs in a room focused on one thing: growing through deals. Three insights that stood out: The wisdom is already in the room. We ran deal speed networking sessions where members shared their specific needs (buying companies, seeking JV partners, raising capital). The collective knowledge and connections in that room solved problems in minutes that could take months to crack alone. Stop looking outside your network for every answer. Exit satisfaction is shockingly low. Dave Hirsch shared that only about 13% of entrepreneurs who successfully exit are actually happy afterward. His "Inner Board Meeting" concept helps you identify all the different voices and aspects of your personality that need to be satisfied by any deal you pursue. Powerful framework for avoiding founder depression. Lifestyle business isn't an insult. Silicon Valley prodigy Fallon Fatemi, who co-founded an AI company with Mark Cuban, shared that she'll never raise capital again. Not because capital is bad, but because her priorities have shifted. Build the business and life YOU want, not what others expect.• • •FOR MORE ON THIS EPISODE:https://www.coreykupfer.com/blog/kraftheinz• • •FOR MORE ON COREY KUPFER:https://www.linkedin.com/in/coreykupfer/http://coreykupfer.com/ Corey Kupfer is an expert strategist, negotiator, and dealmaker. He has more than 35 years of professional deal-making and negotiating experience. Corey is a successful entrepreneur, attorney, consultant, author, and professional speaker. He is deeply passionate about deal-driven growth. He is also the creator and host of the DealQuest Podcast.Get deal-ready with the DealQuest Podcast with Corey Kupfer, where like-minded entrepreneurs and business leaders converge, share insights and challenges, and success stories. Equip yourself with the tools, resources, and support necessary to navigate the complex yet rewarding world of dealmaking. Dive into the world of deal-driven growth today!

According to the Bloomberg School of Public Health at Johns Hopkins University, women make up 70% of the global healthcare workforce but hold only about 25% of leadership positions. Our guest today on Raise the Line, Dr. Roopa Dhatt, has been a leading voice in the movement to correct that imbalance through co-founding an organization called Women in Global Health (WGH), which has established chapters in over 60 countries since it started a decade ago. Dr. Dhatt is also pursuing that agenda and addressing other pressing issues in healthcare as a Young Global Leader at the World Economic Forum. “We're changing the equation so women delivering health are also viewed and valued as leaders,” says the internal medicine physician and assistant professor at Georgetown University School of Medicine. Beyond leadership equity, Dr. Dhatt is also seeking to address systemic pay inequities and high levels of violence and harassment experienced by women in the health sector, issues that were highlighted in research conducted by WGH. Although WGH has seen high-level success influencing policy at the World Health Organization and United Nations, Dr. Dhatt says the heart of its success is local. “Women community health workers have begun to see themselves as leaders and the heroines of health in their communities. That's profound change.” Join host Michael Carrese for a probing conversation that identifies the structural barriers blocking advancement for women and that explains why the health of communities and the planet depend on inclusive leadership.Mentioned in this episode:Women in Global HealthWHO Report: Delivered By Women, Led By MenDr. Roopa Dhatt on LinkedIn If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

FREE SPEECH FRIDAY SUPPORT ME ON PATREON: https://www.patreon.com/c/taylorlorenz   Buy a subscription to my Tech and Online Culture newsletter, User Magazine to support my work!!!!

#037 How You Can Control Your Healthcare Costs explains how your premium costs are a direct reflection of the amounts paid to doctors, hospitals and pharma and what you can do to help yourself lower your costs by comparing.It's Open Enrollment season.  Confused?You can only control what you can control.  If you need help, ring me up at scottwdowling@scottwdowling.comHelp yourself by checking healthcare prices.  Two great spots to look and keep your doctor and hospital honest:Surgery Center of OklahomaMark Cuban Cost Plus DrugsWatch Dr. Keith Smith and Mark Cuban testify before Senate Committee on AgingIs your HSA set up correctly?  If you don't know and want to get ready for 2026, keep an eye out for my upcoming workshop.  Check your balances now and what your plan's maximum out of pocket is for next calendar year.  Don't miss out on saving the most you can with your HSA!  Workshop coming up in late November and early December.Follow me on X: @scottwdowling and @doxcost

Natalie Holloway turned a $5,000 side hustle into Bala — a globally recognized fitness brand worn by millions and backed by Mark Cuban and Maria Sharapova. In this interview, the Bala co-founder breaks down how she and her husband Max bootstrapped the brand from their garage to $20M+ in sales, weathered near-bankruptcy after the post-COVID crash, and rebuilt into a nine-figure company with 20+ products and collaborations with brands like Spanx and Pucci. From surviving massive layoffs to mastering profitability and rebuilding from the ground up, this is a raw, unfiltered look at what it takes to build, lose, and rebuild a modern fitness empire. What you'll learn from this interview: • How Bala grew from a $5K side hustle to a nine-figure global brand • The story behind their $900K Shark Tank deal with Mark Cuban & Maria Sharapova • What really happened after the COVID fitness boom — and how they recovered • The leadership lessons from scaling a 30-person team down to 3 and back again • How to manage co-founding a company with your partner without burning out • The strategy behind Bala's collaborations with Spanx and major lifestyle brands • How to protect your IP, handle copycats, and stay focused on innovation • Why Natalie is now mentoring founders and writing The Bala Playbook to share hard-won lessons By the end of this interview, you'll walk away with a roadmap for building a resilient, profitable, and enduring brand — and the mindset to navigate every high and low along the journey. SAVE 50% ON OMNISEND FOR 3 MONTHS Get 50% off your first 3 months of email and SMS marketing with Omnisend with the code FOUNDR50. Just head to ⁠⁠https://your.omnisend.com/foundr⁠⁠ to get started. HOW WE CAN HELP YOU SCALE YOUR BUSINESS FASTER Learn directly from 7, 8 & 9-figure founders inside Foundr+ Start your $1 trial → ⁠⁠https://www.foundr.com/startdollartrial⁠⁠ PREFER A CUSTOM ROADMAP AND 1-ON-1 COACHING? → Starting from scratch? Apply here → ⁠⁠https://foundr.com/pages/coaching-start-application⁠⁠ → Already have a store? Apply here → ⁠⁠https://foundr.com/pages/coaching-growth-application⁠⁠ CONNECT WITH NATHAN CHAN Instagram → ⁠⁠https://www.instagram.com/nathanchan⁠⁠ LinkedIn → ⁠⁠https://www.linkedin.com/in/nathanhchan/⁠⁠ CONNECT WITH NATALIE HOLLOWAY Website → https://shopbala.com/ Instagram → https://www.instagram.com/natalieholloway/ FOLLOW FOUNDR FOR MORE BUSINESS GROWTH STRATEGIES YouTube → ⁠⁠https://bit.ly/2uyvzdt⁠⁠ Website → ⁠⁠https://www.foundr.com⁠⁠ Instagram → ⁠⁠https://www.instagram.com/foundr/⁠⁠ Facebook → ⁠⁠https://www.facebook.com/foundr⁠⁠ Twitter → ⁠⁠https://www.twitter.com/foundr⁠⁠ LinkedIn → ⁠⁠https://www.linkedin.com/company/foundr/⁠⁠ Podcast → ⁠⁠https://www.foundr.com/podcast

In Episode 491, Stacey Richter interviews Elizabeth Mitchell, CEO of the Purchaser's Business Group on Health (PBGH), about the PBGH Transparency Demonstration Project. They discuss the project's aim to provide jumbo self-insured employers with transparency in healthcare costs, quality, and safety data. Collaborating with Milliman and Embold and funded by the Peterson Center on Healthcare, PBGH's project reveals no correlation between higher prices and quality in healthcare services. The episode highlights the impacts on TPAs, consultants, and clinical organizations, and underscores the importance of employers using this new transparency data for strategic advantage and compliance with the Consolidated Appropriations Act. Richter and Mitchell delve into the broader implications for creating high-value networks and fostering market competition based on quality and affordability. === LINKS ===

What if you could close high-value clients... without pitching, posturing, or even talking about what you sell? This week's guest, Corey Lilburn, is a senior consultant and shareholder at Acrisure, a $35B global insurance and fintech firm. From selling Cutco knives to advising enterprise clients, Corey's success comes from mastering the timing, psychology, and nuance of complex sales. Corey shares the real sales skills that matter in today's market, the habits that create consistent closers, how to make renewals a non-event, and why self-funding might make sense sooner than you think. He also shares what Mark Cuban is getting right about pharma... and how a Sinatra impersonator helped him close a major deal. Plus, we dig into the evolution of Bay Area Advisors and how their Martinis for Moffitt event has raised over $4 million for cancer research. If you're selling high-ticket services or navigating long sales cycles, this one's packed with real strategies that actually work. Tune in and learn how to sell anything to anyone. — This episode is part of the 8FE (8-figure entrepreneur) series, where we talk to entrepreneurs who have already passed the million-dollar mark. — Key Takeaways: 00:00:00 Intro 00:01:37 Essential skills for mastering sales 00:05:03 How AI will impact insurance in the next 5 years 00:07:08 The challenges of risk assessment 00:09:17 Sales cycles and client relationships in insurance 00:22:18 Can you make insurance less boring? 00:23:41 Renewal vs. assumptive close 00:28:23 Keeping healthcare costs down 00:40:45 Self-insurance and level funding 00:53:38 Selling insurance companies to bigger insurance companies 01:06:26 Bay Area Advisors and Martinis for Moffitt 01:20:42 Advice for aspiring entrepreneurs 01:24:35 Outro — Additional Resources:

“They say it takes a village to raise a child. I really think it takes a village to treat a patient,” says Dr. Lanae Mullane, a naturopathic doctor and clinical strategist who has spent years at the forefront of bridging functional medicine, nutraceutical development, and digital health. In this episode of Raise the Line, host Lindsey Smith explores Dr. Mullane's view that naturopathic medicine complements conventional care by expanding -- not replacing -- the clinical toolkit, and that collaboration should be the future of medicine. “At the end of the day, collaboration and connection create the best outcomes for the people we serve,” she says. Their in-depth conversation also spans the shifting landscape of women's hormone health, including the perimenopausal transition and long-overdue calls for research equity. “We're not just smaller versions of men. We need to have dedicated research for us.” Tune in to learn about the importance of grounding health in sustainable habits, rethinking midlife care for women, and how to help patients take ownership of their health.Mentioned in this episode:Joi + BlokesSuppCoDr. Mullane's Clinical Website If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Norm Hitzges sits down with billionaire entrepreneur and former Dallas Mavericks owner Mark Cuban for an unfiltered conversation about life after selling the team, walking away from Shark Tank, and why business still feels like the ultimate sport. Cuban opens up about family life, his growing company Cost Plus Drugs, and his view of American politics—spoiler: he's not a fan of either party.In classic Norm fashion, the chat flows from heartfelt reflections to sharp insight, with plenty of humor along the way. From fake pharmaceutical studies to pitch emails gone wrong, this is Mark Cuban at his candid best — confident, self-aware, and always one step ahead.

This Day in Legal History: Black TuesdayOn October 29, 1929, the United States experienced one of the most catastrophic financial events in its history—Black Tuesday, the climax of the stock market crash that helped trigger the Great Depression. While primarily remembered as an economic crisis, this day also had profound and lasting legal consequences that reshaped American financial regulation and the federal government's role in the economy.In the immediate aftermath, the lack of oversight and rampant speculation that had fueled the 1920s bull market came under intense scrutiny. The legal system responded in the 1930s with a suite of landmark legislative reforms designed to stabilize financial markets and restore public confidence. Chief among these were the Securities Act of 1933 and the Securities Exchange Act of 1934, which established mandatory disclosure requirements for public companies and created the Securities and Exchange Commission (SEC) to enforce federal securities laws.These laws introduced the legal principle that corporations owe a duty of candor to investors and that misleading or fraudulent statements can be subject to civil and criminal penalties. They also laid the foundation for modern financial regulation, including rules governing insider trading, market manipulation, and fiduciary duties of brokers and advisors.The legal legacy of October 29, 1929, is thus not limited to market losses but includes the birth of a federal regulatory framework that continues to govern securities markets today. It marked a turning point where the federal government took a permanent role in policing Wall Street and protecting investors through statutory and administrative mechanisms.The U.S. Court of Appeals for the Second Circuit will hear Argentina's appeal of a $16.1 billion judgment related to its 2012 expropriation of oil company YPF. The judgment, issued by U.S. District Judge Loretta Preska in 2023, awarded $14.39 billion to Petersen Energia Inversora and $1.71 billion to Eton Park Capital Management, former minority shareholders of YPF. They claimed Argentina violated contractual obligations by failing to make a tender offer when it nationalized 51% of YPF from Spanish energy firm Repsol.Argentina argues the case should not be heard in a U.S. court, citing sovereign immunity, misapplication of Argentine law, and the principle of international comity. It also contends the damages are vastly overstated—amounting to 45% of its 2024 national budget. The litigation has been financially backed by Burford Capital, which could receive a large payout if the appeal fails.The appeal arrives as President Javier Milei, a libertarian reformer, works to stabilize Argentina's economy with austerity measures, having recently achieved a rare budget surplus. Meanwhile, Argentina is also separately appealing a court order to hand over YPF shares, an order currently on hold. The U.S. government has not taken a stance on the appeal but opposed the share turnover, citing foreign policy risks.Argentina to ask US appeals court to overturn $16.1 billion YPF judgment | ReutersA federal judge ruled that Bilal Essayli was unlawfully appointed as acting U.S. attorney for California's Central District, which includes Los Angeles. U.S. District Judge J. Michael Seabright found that Essayli's continued service beyond the 120-day interim period allowed by law was improper since he had neither been nominated by the president nor confirmed by the Senate. This decision disqualifies him from serving in the acting role but allows him to remain as first assistant U.S. attorney.The ruling does not dismiss three criminal indictments issued during Essayli's tenure, as they were signed by other prosecutors and no due process violations were found. Still, the judgment raises concerns about leadership stability in the largest federal judicial district in the country, serving roughly 19 million people.Essayli's appointment was part of a broader pattern under the Trump administration of bypassing Senate confirmation for key prosecutorial roles. A similar ruling recently invalidated the acting U.S. attorney appointment in Nevada, and another decision in New Jersey blocked Alina Habba, a Trump ally, from participating in prosecutions. These appointments are now under appeal.Judge disqualifies ‘acting' US attorney in California | ReutersThe celebrity video platform Cameo filed a trademark infringement lawsuit against OpenAI in a California federal court, accusing it of unlawfully using the name “Cameo” for a new feature in its Sora video generation app. Cameo claims that OpenAI's use of the term for AI-generated virtual likenesses causes brand confusion and threatens the distinctiveness of its trademark.OpenAI launched Sora as a standalone app in late September, and its feature—also named “Cameo”—lets users create AI-generated videos that can include virtual celebrities. Cameo argues this directly competes with its own service, where users pay real celebrities for personalized video messages. The company pointed to examples of AI-generated videos featuring public figures like Mark Cuban and Jake Paul, claiming this puts OpenAI in head-to-head competition with their business model.Cameo said it attempted to resolve the issue privately, but OpenAI declined to change the feature's name. OpenAI responded that it disagrees with the lawsuit, arguing no one can monopolize a generic term like “cameo.”The lawsuit seeks financial damages and a court injunction to stop OpenAI from using the name “Cameo.”OpenAI sued for trademark infringement over Sora's ‘Cameo' feature | ReutersTexas has hired the law firm Keller Postman—which previously secured a $1.4 billion settlement from Meta—to lead a new lawsuit alleging that Tylenol use during pregnancy increases the risk of autism in children. Filed in Panola County, the suit accuses Johnson & Johnson and Kenvue, Tylenol's current owner, of misleading consumers by marketing the drug to pregnant women despite knowing potential developmental risks tied to its active ingredient, acetaminophen.Ashley Keller, a senior partner at the firm, said the case will be handled on a contingency basis, meaning Texas pays only if it wins, similar to prior deals with Meta and Google. The firm's effective hourly rate under that model can reach $3,780, though its total fees are capped at 11% of any recovery. Keller defended the state's approach, saying the firm invests heavily and shares the litigation risk with Texas.The lawsuit builds on ongoing national litigation over acetaminophen and childhood developmental disorders, though courts have previously rejected similar claims. A 2024 federal ruling in New York dismissed related cases after expert testimony linking acetaminophen to ADHD was excluded. Texas' case, however, is distinct because it focuses on state-level claims of deceptive trade practices and fraudulent transfer, alleging J&J unlawfully moved Tylenol liabilities to Kenvue.Texas Returns to Keller Postman to Link Tylenol to Child Autism This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.minimumcomp.com/subscribe

“It's kind of a miracle, frankly,” says Dr. John Buse, a distinguished professor at the University of North Carolina School of Medicine, referring to the effectiveness of GLP-1 receptor agonist medications such as Ozempic in treating type 2 diabetes, promoting significant weight loss, and reducing cardiovascular risk. As a physician scientist for the last three decades at UNC, Dr. Buse has played a key role in ushering in this new era of diabetes care, leading or participating in over 200 clinical studies on this class of drugs and others. “Nothing has impacted diabetes care like the GLP-1 receptor agonists. I have lots of patients whose diabetes was never well controlled who have seen all their metabolic problems essentially resolved.”  In this fascinating conversation with Raise the Line host Lindsey Smith, Dr. Buse not only explains how these drugs work, but also provides a clear-eyed look at side effects, and addresses issues of cost and access. Join us for the remarkable story – including the role played by Gila monsters -- behind one of the biggest developments in medicine over the past several years from a world renowned diabetes researcher and clinician. Mentioned in this episode:UNC School of Medicine If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Scott Galloway responds to Mark Cuban's claim that media is a bad investment, breaking down how social platforms, YouTube, and podcasts are redefining where attention and ad dollars flow. He then shares dating advice for women navigating today's digital landscape, and offers guidance for a dentist taking over a high-end practice on how to impress and retain wealthy clients. Want to be featured in a future episode? Send a voice recording to officehours@profgmedia.com, or drop your question in the r/ScottGalloway subreddit. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Subscribe to UnitedHealthcare's Community & State newsletter.Health Affairs' Jeff Byers welcomes Stacie Dusetzina of Vanderbilt University Medical Center and David Simon of the University of Connecticut back to the pod to the current state of drug prices, how proposed tariffs may impact the pharmaceutical industry, that Pfizer deal, what consumers can expect if tariffs are added to prescription drugs, what exactly TrumpRx is, and more.Become an Insider today to get access to our third trend report focusing on the influence of private equity in health care.Related Articles:Trump admin readies 'imminent' probe into other nations' drug pricing, raising new tariff threat: FT (FiercePharma)President Trump's Executive Orders On Prescription Drug Prices: What The Evidence Says (Health Affairs Forefront) Subscribe to UnitedHealthcare's Community & State newsletter.

On this episode of the Somewhat Frank Podcast, Frank Gruber (X and IG: @FrankGruber), John Guidos (IG: jgoodtimes83), Jen Consalvo (X: @noreaster), and Simon Kahan (IG: simonkahan) discuss the following topics: Mark Cuban Slams OpenAI's Erotica Plan — “This Is Going to Backfire” Instagram introduces PG-13 settings Regulators probe Waymo after its robotaxi drove around a stopped school bus Louvre Museum Heist: Nearly$140 Million in Losses We also upload our episodes to YouTube in video format so you can see us now. Check it out on Established YouTube, where you can subscribe to get updates when we drop a new episode at: https://soty.link/ESTYouTube  As always, thank you for listening, and feel free to reach out and let us know what you think at: somewhatfrank@est.us 

In this episode of Relentless Health Value, host Stacey Richter speaks with Shane Cerone and Dr. Sam Flanders of Kada Health about three pervasive myths in the healthcare industry. They discuss the belief in a functioning healthcare market, the necessity of high prices for hospital survival, and the notion that reducing prices means lower quality care. Highlighting the inefficiencies and lack of competition in the current system, they address the importance of transparency and competition. This episode sets the stage for a follow-up discussion focusing on tangible solutions and improvements for the healthcare system. === LINKS ===

“It wasn't a profession, it was a way of life,” observes internationally respected psychiatrist Dr. Nasser Loza, reflecting on a century-long family legacy in mental health care that began when his grandfather founded The Behman Hospital in Cairo. In this candid Raise the Line conversation with host Michael Carrese, Dr. Loza traces the transformation of psychiatry he's witnessed in his long career as increases in classifications, payment bureaucracy, reliance on pharmaceuticals, and technological disruption have each left their mark. The cumulative costs associated with these changes have, he laments, pushed care out of reach for many and hindered the human connection that is key to the discipline. He describes his prescription for countering these trends as a focus on effective and modest aims. “Rather than saying, come and see me in therapy for five years and I will make a better person out of you, I think focusing on symptom-targeted help is going to be what is needed.”  In this wide-ranging interview, you'll also learn about progress on advancing the rights of mental health patients and lowering stigmas, how to manage the rise of online therapy and use of AI chatbots, and the importance of empathy and transparency in mental health counseling. Don't miss this valuable perspective on a critically important dimension of healthcare that's informed by decades of experience as a clinician, government official and global advocate. Mentioned in this episode:The Behman HospitalMaadi Psychology Center If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

elcome back to the Sisterhood of S.W.E.A.T. Podcast — the show that's all about building strength, resilience, and success from the inside out. Today, we're diving into the world of entrepreneurship, investing, and breaking barriers with none other than Rashaun Williams. You may know him as a Guest Shark on ABC's Shark Tank, but his influence stretches far beyond the TV screen. As founder and Chief Investment Officer of Harbinger Sports Partners — a $750 million private equity fund co-launched with Mark Cuban and Steve Cannon — Rashaun is changing the game by investing in professional sports teams. With over 170 investments, 50 exits, and early stakes in companies like Robinhood, Coinbase, Ring, and Lyft, his track record speaks for itself. But Rashaun's passion goes beyond deals — he's committed to financial literacy and giving back through the Kemet Institute, which provides free entrepreneurship and life skills to underserved communities. Today, we'll hear his journey from Wall Street to Shark Tank, the lessons he's learned along the way, and what it really takes to build wealth that lasts. Get ready for an episode packed with inspiration, strategy, and some serious Shark wisdom. Connect with Rashun: Instagram: https://www.instagram.com/rashaun_williams/?hl=en Instagram+1 LinkedIn: https://www.linkedin.com/in/rashaunlwilliams LinkedIn+1 Twitter / X: https://twitter.com/RashaunWilliams How you can stay in touch with Linda: Website Facebook Twitter Instagram Pinterest YouTube SoundCloud   "Proud Sponsors of the Sisterhood of S.W.E.A.T" Essential Formulas

This week, we're exploring the future of direct-to-fan commerce with Joshua Stone, the CEO and Co-Founder of Stuff.io and book.io. Josh has some serious backing, including names like Mark Cuban, Snoop Dogg, and Charles Hoskinson, the co-founder of Ethereum just to name a few, and has been working on building Web3 infrastructure that lets artists sell media directly to fans that fans can own and not just rent. We talk about why streaming doesn't pay most artists, how direct-to-fan can actually create real revenue and why we finally have the technology to let fans own digital music again. Whether you're an artist looking for new revenue streams or just curious about where music commerce is heading, we cover a lot of ground The News! General public ‘more concerned than excited' about increased use of AI   In the AI Age, the Music Industry Needs New Metadata Standards. But Time Is Running Out   Spotify to Develop AI Music Products in Partnership With Major Record Labels    ‘Death to Spotify': the DIY movement to get artists and fans to quit the music app The Music Tectonics podcast goes beneath the surface of the music industry to explore how technology is changing the way business gets done. Visit musictectonics.com to find shownotes and a transcript for this episode, and find us on LinkedIn, Twitter, and Instagram. Let us know what you think!    Get Dmitri's Rock Paper Scanner newsletter.  

Bill Maher and his guests answer viewer questions after the show. (Originally aired 10/17/25) Learn more about your ad choices. Visit podcastchoices.com/adchoices

How do you turn a personal frustration into a $75 million brand—with no experience in the industry? In this episode of Leaders of Transformation, host Nicole Jansen interviews Justin Baer, founder of Collars & Co., who transformed a simple idea—a dress-collar polo shirt—into one of the fastest-growing luxury menswear brands in America. With no background in fashion and a long history of entrepreneurial experiments (and failures), Justin shares how he built a multimillion-dollar brand through relentless action, rapid testing, and the courage to launch imperfect ideas. His story of Shark Tank success and partnership with Mark Cuban reveals how persistence, timing, and customer feedback can turn a simple product into a household name. You'll learn: How to identify business opportunities from everyday frustrations Why “done” is better than “perfect” when launching a new product The power of storytelling and viral marketing (including the TikTok video made by his daughter) How to scale fast while staying true to your brand vision What it takes to go from side hustle to a $75 million business in just three years If you're an entrepreneur, innovator, or aspiring business leader, this conversation will inspire you to take action—before you feel ready—and trust the process of learning, testing, and growing along the way.

“When I was in medical school, no one had even heard of mitochondrial disease. Today, every student who graduates here knows what it is and has seen a patient with it,” says Dr. Mary Kay Koenig, director of the Center for the Treatment of Pediatric Neurodegenerative Disease at UTHealth Houston McGovern Medical School. That remarkable change in awareness has been accompanied by advances in genetic sequencing, the development of clinical guidelines, and the emergence of potential treatments in some forms of mitochondrial disease. In fact, Dr. Koenig's multidisciplinary team at UTHealth's Mitochondrial Center of Excellence has been a key player in clinical trials that may yield the first FDA-approved treatments for it. As you'll learn in this Year of the Zebra conversation with host Michael Carrese, her work in neurodegenerative diseases also includes tuberous sclerosis, where advanced therapies have replaced the need for repeated surgeries, and Leigh Syndrome, which has seen improvements in diagnoses and supportive therapies leading to better quality of life for patients.  Tune in as Dr. Koenig reflects on an era of progress in the space, the rewards of balancing research, teaching and patient care, and the need for more clinicians to center listening, humility and honesty in their approach to caring for rare disease patients and their  families.Mentioned in this episode:Mitochondrial Center of ExcellenceCenter for the Treatment of Pediatric Neurodegenerative Disease If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Dave Rubin of The Rubin Report talks about Bill Maher still showing some TDS symptoms, but also surprising Mark Cuban and the Real Time with Bill Maher audience by pointing out the hypocrisy of pro-Palestine protesters for ignoring the killing of Palestinians by Hamas; a look at the baby-boomer-led “No Kings” protests that you won't see on CNN; a resurfaced clip of Mike Bloomberg calling out Bernie Sanders' liberal hypocrisy to his face that's now going viral; Mike Johnson pointing out to This Week's Jonathan Karl that the “No Kings” protests accidentally proved the anti-Trump protesters are delusional; The View's Joy Behar and Sunny Hostin claiming the “No Kings” protests are proof Americans are worried about authoritarianism; Zohran Mamdani's failed attempt to explain how he would pay for free buses in New York City; Real Time with Bill Maher guests Mark Cuban and Andrew Ross Sorkin being shocked by Maher's warning to Democrats supporting Zohran Mamdani and turning against capitalism; and much more. Today's Sponsors: Perplexity AI - Use the Comet web browser, the new AI-web browser from Perplexity, that will completely change the way you are able to interact with your browser. Download Perplexity's new AI-web browser, Comet, by heading to: https://pplx.ai/RUBIN Plus, right now when you download Comet - you get a month of Rumble Premium for free! Covepure - A countertop water purifier certified to remove up to 99.9% of impurities including fluoride, PFAs, fertilizer runoff, pharmaceuticals, and others. Go to https://covepure.com/rubin to get $200 off for a limited time only! Morgan & Morgan - Morgan & Morgan is America's Largest Injury Law Firm, with over 1,000 attorneys operating in all 50 states. Go to: https://ForThePeople.com/Rubin

Sara Eisen, David Faber, and Carl Quintanilla kicked off the hour looking at fresh data on the China front before breaking down the market picture with Charles Schwab's Chief Investment Strategist Liz Ann Sonders. Plus: why gold and stocks are partying together - according to market veteran Ruchir Sharma, who broke down the rare correlation and why it could lead to an "unpleasant surprise" for investors... and what to do with Netflix shares - ahead of results tomorrow. Also in focus: Mark Cuban telling CNBC that the Trump administration deserves credit for its efforts to reduce drug prices - hear his exclusive comments, this hour... Along with the latest on the huge internet outage sending a number of high profile websites dark this morning... and the regulatory win sending Boeing shares to fresh highs.  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Kirsten Maitland is the co-founder of Rebel Cheese, an award-winning Austin-based vegan cheese brand backed by Shark Tank investor Mark Cuban. A former U.S. Navy veteran and Microsoft agile coach, Kirsten brings her background in tech innovation to reimagine plant-based dairy through traditional cheesemaking techniques and smart Ecommerce strategy.After leaving a stable four-day tech career to pursue purpose over comfort, Kirsten built Rebel Cheese from a six-bottle wine fridge experiment into a nationally recognized brand featured by The New York Times. From launching DTC overnight during COVID to scaling through broken shipments and real-time customer feedback, her journey reveals what it takes to grow authentically while staying true to your values.Whether you're building a mission-driven CPG company or refining your feedback loop before scaling, Kirsten shares a masterclass in transforming curiosity and conviction into sustainable growth.In This Conversation We Discuss:[00:03] Intro[00:55] Bringing tradition into modern food innovation[01:30] Turning passion for food into a scalable concept[02:34] Validating a product through emotional connection[03:33] Turning crisis into new growth channels[04:44] Fixing packaging with help from early partners[06:03] Shipping curated boxes to customers' doors[07:00] Selling out with zero ads or paid marketing[08:00] Turning online orders into lasting connections[08:58] Delaying advertising to protect cash flow[10:21] Stay updated with new episodes[10:31] Learning to sustain momentum after viral moments[12:24] Studying investor dynamics before pitching[12:53] Episode Sponsors: Electric Eye & Heatmap[15:32] Launching fast to gather real customer feedback[18:01] Leveraging AI agents to save time and moneyResources:Subscribe to Honest Ecommerce on YoutubePlant-based cheese you'll actually love rebelcheese.com/Follow Kirsten Maitland linkedin.com/in/kirstenmaitlandSchedule an intro call with one of our experts electriceye.io/connectClear, real-time data built for ecommerce optimization heatmap.com/honestIf you're enjoying the show, we'd love it if you left Honest Ecommerce a review on Apple Podcasts. It makes a huge impact on the success of the podcast, and we love reading every one of your reviews!

#636 What if a simple TikTok video filmed by a seven-year-old could launch a million-dollar business? Or lead to a deal on Shark Tank? In this episode, host Kirsten Tyrrel sits down with Justin Baer, the founder and CEO of Collars & Co., a Mark Cuban-backed menswear brand that's changing how professional men dress. Justin takes us behind the scenes of his entrepreneurial journey — from the initial idea sparked during COVID to scaling the business into a full menswear line. He shares how a simple TikTok video filmed by his seven-year-old daughter turned into $40,000 in sales in the first month, why being willing to fail is key to success, and how giving away your product for free can be a powerful market test. Whether you're launching a product or looking to refine your business strategy, Justin's insights on testing, scaling, and building relationships will give you the confidence to take the next step! (Original Air Date - 3/24/25) What we discuss with Justin: + How a TikTok video sparked $40K in sales + Testing product viability with consignment + Importance of being willing to fail + Scaling from one product to a full brand + Leveraging influencer and social proof marketing + Why giving away products can drive sales + Balancing product uniqueness vs. smart marketing + Building strong relationships with retailers + Transitioning from DTC to omnichannel strategy + Learning and adapting quickly as an entrepreneur Thank you, Justin! Check out Collars & Co. at ⁠CollarsandCo.com⁠. Use coupon code MU to get 20% off your first order. Watch the ⁠video podcast⁠ of this episode! To get access to our FREE Business Training course go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠MillionaireUniversity.com/training⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. And follow us on: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Tik Tok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ To get exclusive offers mentioned in this episode and to support the show, visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠millionaireuniversity.com/sponsors⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Want to hear from more incredible entrepreneurs? Check out all of our interviews ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠! Learn more about your ad choices. Visit megaphone.fm/adchoices

Bill's guests are Arnold Schwarzenegger, Andrew Ross Sorkin, Mark Cuban (Originally aired 10/17/25) Learn more about your ad choices. Visit podcastchoices.com/adchoices

She started as a teenage radio DJ with big dreams and a love for loud music — and turned that passion into a powerhouse television career. On this episode of Takin’ a Walk, Katie Daryl joins the conversation to share her journey from spinning records in Phoenix to becoming the creative force behind AXS TV hits like The Top Ten Revealed and The World’s Greatest Tribute Bands. As the former Vice President of Programming, Katie reveals what it’s like building original rock-focused content, landing her first job by cold-calling Mark Cuban, and interviewing legends from Alice Cooper to Dionne Warwick. It’s a walk through decades of music, television, and fearless creativity with one of entertainment’s most dynamic storytellers.Support the show: https://takinawalk.com/See omnystudio.com/listener for privacy information.

Ben Schwartz, MD, MBA, wrote an article recently, and yeah, he makes a really compelling point. Dr. Schwartz wrote, “Ultimately, the most successful care models are those that create value inherently. The goal isn't simply cost arbitrage; it's creating a sustainable system that makes value attainable. Care delivery innovation is about more than optimizing for VC [venture capital] returns or maximizing operational efficiency.” For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. That mention of value and how to achieve it for real—like, actually create a care model that delivers value inherently—is a great segue to introduce the show this week. It's a continuation of our mission/margin theme, and this week, we're talking about the margin part of the “no margin, no mission” cliché. So, taking this from the top, last week—and go back and listen to that show if you have not yet (and you can listen to both of these parts in no particular order; you do you)—but last week, we talked mission. That part about value and creating value inherently? The tie-in here to mission and margin could be a value equation, really. Like, mission divided by margin is how you calculate the value delivered (less carrier spread), but that's a whole other show with Cynthia Fisher (EP457). So, let me introduce my guest this week, who was also my guest last week: Dan Greenleaf, CEO of Duly, which is a multispecialty group in Chicago. So, last week Dan and I talked mission, as I said; but today we're talking margin, which is, again, gonna be the denominator of so many value equations. Last week in that mission show, quick review (or spoiler alert, depending on the order in which you may be listening to these shows), but last week, Dan Greenleaf broke mission, Duly's mission, into four quadrants. The four quadrants of mission being affordability, access, consumer experience, and quality. In this conversation today, the margin conversation, Dan Greenleaf emphasizes that achieving these four quadrants reduces friction for patients and clinicians that leads to not only better care outcomes but also financial sustainability (ie, margin). Margin can therefore be a function of mission. And again, as Dr. Ben Schwartz put it, “Ultimately, the most successful care models are those that create value inherently.” So, here we go. To be noted with one big fat fluorescent highlighter marker, a big part of this mission that comes up over and over again last week, it's about making prices reasonable and predictable and transparent for patients. Financial toxicity is a thing. Financial toxicity not only is clinical toxicity when so many people are delaying needed care. And look, I don't often quote Marjorie Taylor Greene, but recently she was in the New York Times and was quoted as saying, “The cost of health care is killing people.” This is what we should be focusing on. I just read the other day that one-third of adults in this country are currently delaying or forgoing care due to cost. One-third! Not one-third of low income or something like that. One-third of adults in this country are delaying or forgoing care due to fear of cost. In today's world, affordability and price transparency is part of what customer experience means—not just, like, lemon water in the waiting room. This is what struck me the most about the conversation from last week. But wait. Does affordable for patients spell trouble when it comes to the margin part of the operation? Will an affordability mission wreak havoc on margin? Is this business model doomed? Is there even a successful care model that creates value inherently that is sustainable? Such a good question, which is why I ask it to Dan Greenleaf right out of the gate. So, just to sum this all up in the conversation that follows, Dan Greenleaf gets into the challenges and the strategies involved in balancing mission-driven healthcare with financial realities. Duly's approach to being fiscally solid includes, well, I'm just gonna say many of the same types of efficiency things to maintain and retain margin that other more mainstream health systems might deploy. But I'd say there's a really striking difference in the why and the how. And the impact of this why and how is striking when you look at Duly's prices and the impact it has on its overall community. So, even though it's using similar types of strategies, maybe, as big consolidated health systems or other organizations, the impact and what it all adds up to is, again, very, very different. This is what I mean. At health systems, and maybe my head is just lost in a couple of anecdotal bits of evidence right now, but I just had two conversations in the past two days with physician leaders at big health systems (different ones), but both of these individuals said variations of the same theme. And if you wanna picture the scene, picture the saddest expressions, and one of them had a martini and the other one had a big-boy glass of wine. And both of them said, Look, my organization has lost sight of patient care, but also my organization has lost sight of, like, financial goals in most parts of the organization. All I seem to do all day is play politics with a whole lot of middle managers or even senior leaders jockeying for position and having turf wars within these sprawling bureaucracies. These are just great people who are trying so hard to do the right thing and are just struggling to find the foothold to do so within their own organizations. So, let's just say it was refreshing to hear Dan Greenleaf talk about an alignment of incentives and hook the margin up with the mission train in a really tight way throughout the entire organization. And to do this really well—achieve that mission/margin alignment across the whole entire organization—Dan underscores the value of clinician involvement in leadership and having, as I just said, aligned incentives with clinical teams. Keep in mind, this is the margin show, where clinical leadership came up and the number of doctors on their board and the level of physician ownership in the organization. I'm highlighting that this is the margin show here because usually so-called dyad leadership with physicians in leadership roles only comes up in mission conversations, right? Like, in situations where somebody wants the doctor to be the defender of mission and the battle to keep the MBAs in check. And I say this as the comic book stereotype, obviously. But yeah, it's true often enough. But then we have Dan, who is thinking about clinicians who have, again, aligned incentives across the organization so you don't have your physician leaders day drinking while I'm sitting across from them finding myself quoting Sun Tzu The Art of War and helping them craft the perfect PowerPoint slide to weaponize a reorg. Honestly, in my experience, there's no better way to waste metric assloads of money than in an organization where personal power grabs start to supersede anything that smells vaguely like an organizational imperative. And again, these just big bureaucracies at many health systems … yeah, too big not to fail at this is often the way of it. Then lastly, I grilled Dan Greenleaf about capital partners and how to manage to achieve private equity (PE) funding, where there's support for a model that delivers inherent value—a model that benefits both patients and providers as well as investors. And I'm saying this, keeping all of the things that Yashaswini Singh, PhD, said in that episode (EP474) about private equity a few weeks ago. Go back and listen to that. And by the way, Dan Greenleaf in this show has roughly the same ideas as Tom X. Lee, MD (EP445), founder of One Medical and Galileo told me, and also Rushika Fernandopulle, MD (EP460), founder of Iora. Great minds think alike. So, should figuring out how to work with PE be a topic of interest, there you go. Listen to my conversation today with Dan Greenleaf and then go back and listen to those other two shows. Dan Greenleaf, CEO of Duly, my guest today, has been in healthcare for 30 years. He's a six-time CEO: three public companies and has also run three companies backed by private equity and thus very aware of the many different funding mechanisms that exist in the marketplace. This podcast is sponsored by Aventria Health Group, but I do just wanna mention that Duly offered Relentless Health Value some financial support, which we truly appreciate. So, call this episode not only sponsored by Aventria but also Duly. And with that, here is my conversation with Dan Greenleaf. Also mentioned in this episode are Duly Health and Care; Benjamin Schwartz, MD, MBA; Cynthia Fisher; Cristin Dickerson, MD; Yashaswini Singh, PhD; Tom X. Lee, MD; Galileo; Rushika Fernandopulle, MD; Vivian Ho, PhD; Scott Conard, MD; Stanley Schwartz, MD; Vivek Garg, MD, MBA; and Dave Chase. You can learn more at Duly Health and Care and follow Dan on LinkedIn. You can also email Dan at dan.greenleaf@duly.com.   Daniel E. Greenleaf is the chief executive officer of Duly Health and Care, one of the largest independent, multispecialty medical groups in the nation. Duly employs more than 1700 clinicians while serving 1.5 million patients in over 190 locations in the greater Chicago area and across the Midwest. The Duly Health and Care brand encompasses four entities—DuPage Medical Group, Quincy Medical Group, The South Bend Clinic, and a value-based care organization. Its scaled ancillary services include 6 Ambulatory Surgery Centers, 30 lab sites, 16 imaging sites, 39 physical therapy locations, and 100 infusion chairs. Its value-based care service line provides integrated care for 290,000 partial-risk and 100,000 full-risk lives (Medicare Advantage and ACO Reach). Dan has nearly 30 years of experience leading healthcare services organizations. He is a six-time healthcare CEO, including prior roles as president and CEO of Modivcare; president and CEO of BioScrip, Inc.; chairman and CEO of Home Solutions Infusion Services; and president and CEO of Coram Specialty Services. Dan graduated from Denison University with a bachelor of arts degree in economics (where he received the Alumni Citation—the highest honor bestowed upon a Denisonian) and holds an MBA in health administration from the University of Miami. A military veteran, he was a captain and navigator in the United States Air Force and served in Operation Desert Storm.   09:56 How does Dan achieve his mission given the realities of margin? 14:49 How Duly Health's approach and incentives differ from other health systems. 16:04 EP466 with Vivian Ho, PhD. 16:28 EP462 with Scott Conard, MD. 16:31 Summer Shorts episode with Stan Schwartz, MD. 17:27 EP460 with Rushika Fernandopulle, MD. 17:29 EP445 with Tom X. Lee, MD. 17:30 EP407 with Vivek Garg, MD, MBA. 18:50 How having physicians on the hospital board greatly improves margin and mission. 20:04 How Dan explains his approach to his capital partners. 22:23 Fee for service vs. institutional care.   You can learn more at Duly Health and Care and follow Dan on LinkedIn. You can also email Dan at dan.greenleaf@duly.com.   @d_greenleaf of @dulyhealth_care discusses #margin creating a path to #mission in #multispecialtycare on our #healthcarepodcast. #healthcare #podcast #financialhealth #patientoutcomes #primarycare #digitalhealth #healthcareleadership #healthcaretransformation #healthcareinnovation   Recent past interviews: Click a guest's name for their latest RHV episode! Dan Greenleaf (Part 1), Mark Cuban and Cora Opsahl, Kevin Lyons (Part 2), Kevin Lyons (Part 1), Dr Stan Schwartz (EP486), Dr Cristin Dickerson, Elizabeth Mitchell (Take Two: EP436), Dave Chase, Jonathan Baran (Part 2), Jonathan Baran (Part 1), Jonathan Baran (Bonus Episode)  

Tom Haberstroh, Amin Elhassan and producer Anthony Mayes woke up early to crush through Mark Cuban's second appearance on PTFO, and they didn't use ChatGPT to summarize it for you. Truth Teller Michael C. Wright of ESPN joins us to discuss his story about Victor Wembenyama's ambitious and diverse summer activities, react live to Harrison Barnes' AI music video and announce his upcoming Texas two step with Banned MacMahon. Basketball Illuminati is now part of the Count The Dings Network. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Join the Count The Dings Patreon⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to support the show, get ad free episodes and exclusive content at⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.patreon.com/countthedings⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ILLUMINATI MERCH HAS RETURNED⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ - Check it out here:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/CTDMERCH⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Subscribe to Basketball Illuminati! On⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Apple⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Spotify⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠Watch Truth Teller Interviews on YouTube⁠⁠⁠⁠⁠⁠⁠⁠⁠ Email us: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠basketballilluminati@gmail.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Twitter: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@bballilluminati⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@basketballilluminati⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

OpenAI will soon let verified adults access mature content in ChatGPT—including erotica and customizable personalities—under its new “treat adults like adults” policy. CEO Sam Altman said earlier limits were to protect vulnerable users but can now be safely relaxed. The move sparked backlash from figures like Mark Cuban and Vivek Ramaswamy, who warned it could harm trust and worsen AI-related loneliness, while supporters see it as advancing user freedom and personalization. In the headlines: Citigroup's AI saves developers 100,000 hours weekly, Walmart adds AI shopping to ChatGPT, Salesforce expands its OpenAI partnership, Intel readies a new GPU, and Oracle will deploy 50,000 AMD chips.Brought to you by:Is your enterprise ready for the future of agentic AI?⁠⁠⁠⁠⁠Visit AGNTCY.org⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Visit Outshift Internet of Agents⁠⁠⁠⁠⁠Google Gemini - Try NotebookLM today https://notebooklm.google.com/KPMG – Discover how AI is transforming possibility into reality. Tune into the new KPMG 'You Can with AI' podcast and unlock insights that will inform smarter decisions inside your enterprise. Listen now and start shaping your future with every episode. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.kpmg.us/AIpodcasts⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Blitzy.com - Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://blitzy.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to build enterprise software in days, not months Robots & Pencils - Cloud-native AI solutions that power results ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://robotsandpencils.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Vanta - Simplify compliance - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://vanta.com/nlw⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Agent Readiness Audit from Superintelligent - Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://besuper.ai/ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠to request your company's agent readiness score.The AI Daily Brief helps you understand the most important news and discussions in AI. Subscribe to the podcast version of The AI Daily Brief wherever you listen: https://pod.link/1680633614Interested in sponsoring the show? nlw@aidailybrief.ai

"Have you never scored a game?" "No, because I'm an adult who has sex." It's Internet-Brained Truth-Poster vs. Internet-Brained Truth-Poster in the latest episode of Harvard Huckster Finds Out. We also head back to Days of Yore for an audio description of a wild baseball play. Learn more about your ad choices. Visit podcastchoices.com/adchoices

After tweeting 17,053 words in defense of his fellow billionaire NBA owner, the most polarizing member of Team Ballmer is back — in-studio — to confront all of Pablo's most burning questions: Why was Kawhi Leonard's deal kept so secret? When did the Clippers really know? Just how screwed was Aspiration? And what the hell do Cuban's Mavericks and the Knicks' Jalen Brunson have to do with this scandal?• Part I: The Richest Owner in Sports, the Silent Superstar and the Rotten Apple Tree• Part II: Team Ballmer vs. Team Sh*tting Bricks — an Argument with Mark Cuban• Part III: The Mystery Investor, the No-Show Payday and the "Smoking Gun"• Part IV: Steve Ballmer, the Other Cuban and the $118 Million Infusion• Part V: Steve Ballmer's "Inconceivable" Donation, the $20 Million Guarantee and a Head on a Spike(Pablo Torre Finds Out is independently produced by Meadowlark Media and distributed by The Athletic. The views, research and reporting expressed in this episode are solely those of Pablo Torre Finds Out, and do not reflect the work or editorial input of The Athletic or its journalists.) Hosted on Acast. See acast.com/privacy for more information.

The Foundr Podcast with Nathan Chan is where ambitious founders get real playbooks, not theory. Every week, Nathan sits down with the world's top entrepreneurs and operators to unpack how they built, scaled, and led category-defining companies. You'll hear candid stories, hard numbers, and step-by-step tactics you can use right away across product, marketing, hiring, funding, and leadership. Past guests include Mark Cuban, Seth Godin, Tim Ferriss, Barbara Corcoran, Daymond John, and more. If you want to find your product, launch faster, grow revenue, and lead with clarity, this show is for you. Follow now and start building with proven frameworks from the best in the game.